AParadise Acquisition Business Summary

AParadise Acquisition Corp. (APAD) is a special purpose acquisition company (SPAC) currently finalizing a $1.2 billion business combination with Enhanced Ltd., a pioneer in the "performance-enhanced" sports and longevity medicine sector. As of February 2026, the company is transitioning from a blank-check entity to an operational holding company, Enhanced Group Inc., with a planned listing on the NYSE under the ticker ENHA. The revenue model is diversified across three core segments: direct-to-consumer (DTC) telehealth services and performance-optimizing products, media and broadcasting rights for the inaugural 2026 Enhanced Games, and strategic brand partnerships. APAD positions itself as a high-growth disruptor in the global sports and media market, competing directly with TKO Group Holdings (UFC/WWE), the International Olympic Committee (IOC), and other entertainment-focused SPACs such as SilverBox Corp IV and Cantor Equity Partners. The leadership team is anchored by Claudius Tsang, who serves as CEO, CFO, and Chairman, leveraging a 20-year career in private equity including his role as Co-head of Private Equity (North Asia) at Templeton Asset Management. The current board of directors includes independent members Ashley Bancroft, Nathan Pau, and Tracy Hui Yin Choi. Post-merger, the executive suite will be bolstered by Enhanced’s founding team, including CEO Maximilian Martin and Executive Chairman Christian Angermayer, a prominent biotech investor and founder of Apeiron Investment Group. The company is backed by a sophisticated roster of institutional investors, including Apeiron, Tenor Capital Management, and Linden Advisors, reflecting strong market confidence in the intersection of elite sports and performance science.